Live Feeds
● LIVE Updated 1h ago · 33 sources tracked

Towards Conversational AI for Disease Management

Recent studies on agentic AI models indicate potential to assist in diagnosis, treatment, and hospital admissions. Despite these capabilities, these models are not yet prepared for real-world clinical application. Current benchmarks are criticized for lacking actual patient environments.

RSS Source map (28)

What changed

New reports clarify that while AI agents can aid decision-making, they remain unfit for actual clinical use.

Live updates

  1. Medical AI Agents Show Progress but Lack Clinical Readiness

    Recent studies on agentic AI models indicate potential to assist in diagnosis, treatment, and hospital admissions. Despite these capabilities, these models are not yet prepared for real-world clinical application. Current benchmarks are criticized for lacking actual patient environments.

    What's confirmed:

    • Agentic AI models could assist with patient management stages including diagnosis, treatment, and hospital admission.
    • Neither agentic AI model is ready for real-world clinical use.

    Still unconfirmed:

    • Two medical AIs beat doctors in Nature benchmarks within environments that lacked patients.
    confidence 90%
  2. Google's AMIE AI Shows Potential in Disease Management Simulations

    Google's AMIE system can match or exceed primary care physicians in disease management within simulated environments. A separate real-world trial of a generative AI support tool improved clinical decision-making quality but did not alter short-term patient outcomes. These developments follow recent research published in Nature.

    What's confirmed:

    • Google's AMIE system demonstrates the potential to match or surpass primary care physicians in disease management within simulated environments.
    • Research regarding AMIE was published in the journal Nature.

    Still unconfirmed:

    • AI has surpassed doctors in real EHR processes and multi-round disease management.
    • AI outperforms physicians but not at actual medicine.
    • A generative AI support tool in primary care was safe and improved decision-making quality without changing short-term patient outcomes.
    • Chuck Hemann is the new chief business, AI officer at Assembled Intelligence.
    confidence 80%
  3. Google AMIE and MIRA Match Physician Performance in Nature Study

    Two AI models, Google's AMIE and MIRA, demonstrated the ability to assist with patient management from diagnosis to treatment. Research published in Nature shows these conversational tools perform at least as well as doctors in simulated settings. AMIE is not yet ready for clinical use and requires real-world testing.

    What's confirmed:

    • Research published in Nature on June 17, 2026, presents two AI models, AMIE and MIRA, that can assist with diagnosis and treatment decisions.
    • AMIE and MIRA perform at least as well as physicians in simulated clinical settings.
    • AMIE scored higher than primary care physicians on measures of investigation precision, treatment precision, guideline alignment, and plan appropriateness.
    • AMIE is not ready for clinical use and needs prospective real-world testing.
    confidence 100%
  4. Google's AMIE AI Matches Doctors in Disease Management Reasoning

    Google Research developed the Articulate Medical Intelligence Explorer (AMIE), an agentic system for multi-visit clinical management. A study published in Nature indicates AMIE is non-inferior to primary care physicians in management reasoning. The system uses Gemini for long-context reasoning to align with clinical guidelines and drug formularies.

    What's confirmed:

    • AMIE was compared to 21 primary care physicians across 100 multi-visit case scenarios in a randomized, blinded virtual OSCE study.
    • Specialists assessed AMIE as non-inferior to primary care physicians in management reasoning.
    • AMIE scored better than physicians in treatment and investigation preciseness and alignment with clinical guidelines.
    • The system utilizes Gemini's long-context capabilities and a two-agent architecture consisting of a Dialogue Agent and a Management Reasoning Agent.
    • A new RxQA benchmark of 600 multiple-choice questions from national drug formularies was used to evaluate medication reasoning.
    • The research was published in Nature on 17 June 2026.

    Still unconfirmed:

    • MIRA integrates with electronic health records to request diagnostic tests and recommend hospital admissions.
    confidence 100%